10/27

2021

Chemistry Seminar Series: Mass Spectrometry Tools To Solve Chemical and Biological Problems

Online
Pieter Dorrenstein, Ph.D., Chemistry Professor and Director, Collaborative Mass Spectrometry Innovation Center; Co-Director, Institute for Metabolomics Medicine; Skaggs School of Pharmacy and Pharmaceutical Sciences; University of California — San Diego
Pieter Dorrenstein, Ph.D. presents Mass Spectrometry Tools To Solve Chemical and Biological Problems

It is difficult to assess from human metabolomics samples if a molecule is made by microbes or not. In our lab’s synthesis-based reverse metabolomics approach, MS/MS spectra are acquired from newly synthesized compounds and searched against public metabolomics data to uncover their phenotypic associations. Proof of concept was demonstrated: a total of 16,587 spectral matches were found for 145 amidates synthesized, representing the single largest expansion of structures in the 170+ year history of bile acids. Some new bile acids were associated with health-related phenotypes such as inflammatory bowel diseases and obesity. Follow-on validation in human cohorts revealed that some cholic and chenodeoxycholic acid conjugates were elevated in Crohn’s disease, of which some were also potent PXR agonists. Because searching repositories with MS/ MS spectra has only recently become possible, this synthesis-based reverse metabolomics approach can now be employed as a general strategy to elucidate structures and discover other new molecules from human and animal ecosystems. 

Event Zoom Information

Address

United States

Contact

Amy Deveau
Image
Flyer for Pieter Dorrestein, Ph.D., presents Mass Spectrometry Tools to Solve Chemical and Biological Problems event

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.